Pinnacle Associates’s Loxo Oncology, Inc LOXO Stock Holding History

Pinnacle Associates’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,005	Closed	-$561K	–	735
2018 Q4	$561K	Sell	4,005 -320	-7%	-$48.6K	0.01%	494
2018 Q3	$739K	Sell	4,325 -1,795	-29%	-$302K	0.02%	462
2018 Q2	$1.06M	Sell	6,120 -5,905	-49%	-$887K	0.02%	396
2018 Q1	$1.39M	Buy	12,025 +6,665	+124%	+$709K	0.03%	356
2017 Q4	$451K	Buy	+5,360	New	+$447K	0.01%	509

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Pinnacle Associates's LOXO Position: Q1 2019 in Review

Pinnacle Associates sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 4,005 shares — an estimated $561K sold.

Pinnacle Associates first reported a position in LOXO in Q4 2017 and held it in 5 quarters. The position peaked at $1.39M in Q1 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Pinnacle Associates reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Pinnacle Associates sold 4,005 Loxo Oncology, Inc shares in Q1 2019, an estimated $561K.
Pinnacle Associates first reported a position in Loxo Oncology, Inc in Q4 2017 and held it in 5 quarters.
Pinnacle Associates's Loxo Oncology, Inc position peaked at $1.39M in Q1 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Pinnacle Associates's 13F filing for Q1 2019, filed 10 May 2019.